| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MAD2L1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CLIP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SMIM8 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | MEAF6 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | LRFN2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | FREM2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SDHD | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | SYT6 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MPC1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
